Yale Epidemiologist Dr. Harvey A. Risch Says Hydroxychloroquine & Azithromycin Very Beneficial for Wuhan Outpatients

Translate:

Published yesterday in the American Journal of Epidemiology is a paper from Yale School of Medicine professor Harvey A. Risch enthusiastically recommending hydroxychloroquine with azithromycin for outpatient care of the wuhan virus, very beneficial for those with co-morbidities. In the abstract of the paper, Risch recommends the widespread use of this drug combination, so president Trump may ask for more input from him, but in the meantime spread the word!